In health, the immune system plays a key role in protecting us not only from infectious disease, but also from the development of cancer; immune cells recognize and destroy harmful agents, whether pathogens or malignant cells.
As adolescents return to school, public health experts caution parents to pay close attention to signs of tobacco use among teens.
In a study by Yale Cancer Center, researchers show stem-like T cells within certain lymph nodes could be natural cancer fighters.
An advanced type of radiation therapy at Miami Cancer Institute, part of Baptist Health South Florida, is offering patients ablative MR-guided radiation therapy, which may prolong survival for patients with inoperable pancreatic cancer.
FDA has granted an orphan drug designation to the active ingredient hypericin (HyBryte) for the treatment of T-cell lymphoma, extending the target population beyond cutaneous T-cell lymphoma as previously granted.
Science 37, Foundation Medicine collaborate on interventional home-based clinical trials in oncology
Science 37 and Foundation Medicine are collaborating to enable decentralized clinical research in oncology that will optimize recruitment and enrollment, improve patient retention, and expand access to precision cancer care.
University of Virginia Cancer Center was awarded an NCI Comprehensive Cancer Center designation, effective Feb. 1, 2022.
Amy Heimberger was named the Jean Malnati Miller Professor of Brain Tumor Research and scientific director of the Lou and Jean Malnati Brain Tumor Institute at the Lurie Cancer Center of Northwestern University.
Ben Ho Park, Cornelius Abernathy Professor of Medicine, was named deputy director of Vanderbilt-Ingram Cancer Center.
Sue S. Yom was appointed chair of NRG Oncology’s Head and Neck Cancer Committee.
